Suppr超能文献

根据腰围而非体重指数定义的肥胖与更高的肾脏质量复杂性相关。

Obesity as defined by waist circumference but not body mass index is associated with higher renal mass complexity.

作者信息

Bertrand Laura A, Thomas Lewis J, Li Peng, Buchta Claire M, Boi Shannon K, Orlandella Rachael M, Brown James A, Nepple Kenneth G, Norian Lyse A

机构信息

Department of Urology, The University of Iowa Carver College of Medicine, Iowa City, IA.

Department of Biostatistics, School of Public Health, The University of Alabama at Birmingham, Birmingham, AL.

出版信息

Urol Oncol. 2017 Nov;35(11):661.e1-661.e6. doi: 10.1016/j.urolonc.2017.06.058. Epub 2017 Aug 7.

Abstract

OBJECTIVES

Obesity, typically defined as a body mass index (BMI)≥30kg/m, is an established risk factor for renal cell carcinoma (RCC) but is paradoxically linked to less advanced disease at diagnosis and improved outcomes. However, BMI has inherent flaws, and alternate obesity-defining metrics that emphasize abdominal fat are available. We investigated 3 obesity-defining metrics, to better examine the associations of abdominal fat vs. generalized obesity with renal tumor stage, grade, or R.E.N.A.L. nephrometry score.

METHODS AND MATERIALS

In a prospective cohort of 99 subjects with renal masses undergoing resection and no evidence of metastatic disease, obesity was assessed using 3 metrics: body mass index (BMI), radiographic waist circumference (WC), and retrorenal fat (RRF) pad distance. R.E.N.A.L. nephrometry scores were calculated based on preoperative CT or MRI. Univariate and multivariate analyses were performed to identify associations between obesity metrics and nephrometry score, tumor grade, and tumor stage.

RESULTS

In the 99 subjects, surgery was partial nephrectomy in 51 and radical nephrectomy in 48. Pathology showed benign masses in 11 and RCC in 88 (of which 20 had stage T3 disease). WC was positively correlated with nephrometry score, even after controlling for age, sex, race, and diabetes status (P = 0.02), whereas BMI and RRF were not (P = 0.13, and P = 0.57, respectively). WC in stage T2/T3 subjects was higher than in subjects with benign masses (P = 0.03). In contrast, subjects with Fuhrman grade 1 and 2 tumors had higher BMI (P<0.01) and WC (P = 0.04) than subjects with grade 3 and 4 tumors.

CONCLUSIONS

Our data suggest that obesity measured by WC, but not BMI or RRF, is associated with increased renal mass complexity. Tumor Fuhrman grade exhibited a different trend, with both high WC and BMI associated with lower-grade tumors. Our findings indicate that WC and BMI are not interchangeable obesity metrics. Further evaluation of RCC-specific outcomes using WC vs. BMI is warranted to better understand the complex relationship between general vs. abdominal obesity and RCC characteristics.

摘要

目的

肥胖通常定义为体重指数(BMI)≥30kg/m²,是肾细胞癌(RCC)的既定危险因素,但矛盾的是,它与诊断时疾病进展程度较低及预后改善相关。然而,BMI存在固有缺陷,且有强调腹部脂肪的替代肥胖定义指标。我们研究了3种肥胖定义指标,以更好地检验腹部脂肪与全身性肥胖分别与肾肿瘤分期、分级或R.E.N.A.L.肾计量评分之间的关联。

方法与材料

在一个前瞻性队列中,对99例接受肾肿块切除术且无转移疾病证据的患者,使用3种指标评估肥胖情况:体重指数(BMI)、影像学腰围(WC)和肾后脂肪(RRF)垫距离。根据术前CT或MRI计算R.E.N.A.L.肾计量评分。进行单因素和多因素分析,以确定肥胖指标与肾计量评分、肿瘤分级和肿瘤分期之间的关联。

结果

在这99例患者中,51例行部分肾切除术,48例行根治性肾切除术。病理显示11例为良性肿块,88例为肾细胞癌(其中20例为T3期疾病)。即使在控制年龄、性别、种族和糖尿病状态后,WC仍与肾计量评分呈正相关(P = 0.02),而BMI和RRF则不然(分别为P = 0.13和P = 0.57)。T2/T3期患者的WC高于良性肿块患者(P = 0.03)。相比之下,Fuhrman 1级和2级肿瘤患者的BMI(P<0.01)和WC(P = 0.04)高于3级和4级肿瘤患者。

结论

我们的数据表明,通过WC而非BMI或RRF测量的肥胖与肾肿块复杂性增加相关。肿瘤Fuhrman分级呈现不同趋势,高WC和BMI均与低级别肿瘤相关。我们的研究结果表明,WC和BMI不是可互换的肥胖指标。有必要进一步评估使用WC与BMI对肾细胞癌特定结局的影响,以更好地理解全身性肥胖与腹部肥胖和肾细胞癌特征之间的复杂关系。

相似文献

1
Obesity as defined by waist circumference but not body mass index is associated with higher renal mass complexity.
Urol Oncol. 2017 Nov;35(11):661.e1-661.e6. doi: 10.1016/j.urolonc.2017.06.058. Epub 2017 Aug 7.
2
Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: a prospective multicenter Italian cohort study.
Urol Oncol. 2013 Oct;31(7):997-1002. doi: 10.1016/j.urolonc.2011.08.007. Epub 2011 Sep 16.
3
Visceral obesity and risk of high grade disease in clinical t1a renal cell carcinoma.
J Urol. 2013 Feb;189(2):447-53. doi: 10.1016/j.juro.2012.09.030. Epub 2012 Dec 14.
4
9
Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited.
J Card Fail. 2011 May;17(5):374-80. doi: 10.1016/j.cardfail.2011.01.009. Epub 2011 Mar 25.

引用本文的文献

1
Risk Factors Associated With Unplanned Conversion to Open in Radical and Partial Nephrectomy.
Cureus. 2025 Jun 1;17(6):e85168. doi: 10.7759/cureus.85168. eCollection 2025 Jun.
3
Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets.
Nat Rev Urol. 2023 Jan;20(1):48-60. doi: 10.1038/s41585-022-00654-6. Epub 2022 Oct 3.
4
Re-Evaluating the Effects of Obesity on Cancer Immunotherapy Outcomes in Renal Cancer: What Do We Really Know?
Front Immunol. 2021 Aug 5;12:668494. doi: 10.3389/fimmu.2021.668494. eCollection 2021.
5
Gender-Related Approach to Kidney Cancer Management: Moving Forward.
Int J Mol Sci. 2020 May 10;21(9):3378. doi: 10.3390/ijms21093378.
6
Relationship between body composition indicators and risk of type 2 diabetes mellitus in Chinese adults.
BMC Public Health. 2020 Apr 6;20(1):452. doi: 10.1186/s12889-020-08552-5.
7
The BMI Paradox and Robotic Assisted Partial Nephrectomy.
Front Surg. 2020 Jan 9;6:74. doi: 10.3389/fsurg.2019.00074. eCollection 2019.
8
Prognostic biomarkers in renal cell carcinoma: is there a relationship with obesity?
Transl Androl Urol. 2019 May;8(Suppl 2):S138-S146. doi: 10.21037/tau.2018.11.10.
9
The obesity paradox in cancer: clinical insights and perspectives.
Eat Weight Disord. 2018 Apr;23(2):185-193. doi: 10.1007/s40519-018-0489-y. Epub 2018 Feb 28.

本文引用的文献

1
Obesity and Kidney Cancer.
Recent Results Cancer Res. 2016;208:81-93. doi: 10.1007/978-3-319-42542-9_5.
2
Renal cell carcinoma survival and body mass index: a dose-response meta-analysis reveals another potential paradox within a paradox.
Int J Obes (Lond). 2016 Dec;40(12):1817-1822. doi: 10.1038/ijo.2016.171. Epub 2016 Sep 30.
3
Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.
J Clin Oncol. 2016 Oct 20;34(30):3655-3663. doi: 10.1200/JCO.2016.66.7311.
4
Defining Renal Masses: Comprehensive Comparison of RENAL, PADUA, NePhRO, and C-Index Score.
Clin Genitourin Cancer. 2017 Apr;15(2):248-255.e1. doi: 10.1016/j.clgc.2016.07.029. Epub 2016 Aug 8.
7
R.E.N.A.L. nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy.
Int J Clin Oncol. 2016 Apr;21(2):367-372. doi: 10.1007/s10147-015-0879-3. Epub 2015 Jul 29.
10
Obesity paradox in cancer: new insights provided by body composition.
Am J Clin Nutr. 2014 May;99(5):999-1005. doi: 10.3945/ajcn.113.071399. Epub 2014 Feb 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验